Patent 9005293
Extensions
Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.
Active provider: Google · gemini-2.5-flash
Extensions
Patent term adjustments, term extensions, continuations, divisionals, family members, and expiration dates.
To provide a comprehensive analysis for US Patent 9,005,293, I will access the USPTO Patent Public Search database. As the current date is April 26, 2026, I will focus on up-to-date information regarding patent term adjustments, extensions, and family members.
Patent Term Adjustments (PTA)
Patent Term Adjustment (PTA) is granted to compensate applicants for delays caused by the USPTO during the prosecution of a patent application. This can include delays such as the USPTO failing to issue a first office action within 14 months of filing, failing to respond to an applicant's reply within four months, or failing to issue the patent within four months of payment of the issue fee, among other reasons. The total PTA is added to the 20-year lifespan of the issued patent.
To determine the specific PTA for US Patent 9,005,293, one would typically look for the "Issue Notification" or "Patent Term Adjustment" section within the patent's file history on the USPTO's Patent Center. This information is usually provided by the USPTO at the time of patent issuance. However, the provided patent text does not explicitly state the amount of PTA granted. Without direct access to the USPTO's Patent Center or the issue notification for US9005293, the exact PTA cannot be definitively stated.
Patent Term Extensions (PTE)
Patent Term Extension (PTE) is available for patents claiming products, or methods of using or manufacturing them, that require regulatory approval (e.g., from the FDA) before commercial marketing. The purpose of PTE is to restore a portion of the patent term lost during the regulatory review process. PTE is typically limited to a maximum of five years and cannot extend the patent term over 14 years from the date of marketing approval.
For US Patent 9,005,293, which relates to medical devices for spinal fusion, it could be eligible for PTE if the patented product was subject to a regulatory review period prior to its commercial marketing. However, the provided patent text and the Google Patents abstract and metadata do not indicate that an application for PTE has been filed or granted for US9005293. Applications for PTE are filed within 60 days of regulatory agency approval. Without information from the USPTO's official PTE records, it cannot be confirmed whether US9005293 has received or applied for any PTE.
Continuation Applications, Divisional Applications, and Related Family Members
US Patent 9,005,293 is explicitly identified as a Continuation Application of application Ser. No. 11/842,855, filed on Aug. 21, 2007 (now U.S. Pat. No. 7,942,903). [cite: The patent text provided by the user includes this information in the "CROSS-REFERENCE TO RELATED APPLICATIONS" section.]
Furthermore, it claims priority from a chain of prior applications, making them related family members:
- Continuation-In-Part (CIP) of application Ser. No. 11/536,815, filed on Sep. 29, 2006 (now U.S. Pat. No. 7,846,188). [cite: The patent text provided by the user includes this information in the "CROSS-REFERENCE TO RELATED APPLICATIONS" section.]
- Continuation-In-Part (CIP) of application Ser. No. 11/208,644, filed on Aug. 23, 2005 (now U.S. Pat. No. 7,704,279). [cite: The patent text provided by the user includes this information in the "CROSS-REFERENCE TO RELATED APPLICATIONS" section.]
- Claims priority under 35 U.S.C. §119(e) of U.S. provisional application No. 60/670,231, filed on Apr. 12, 2005. [cite: The patent text provided by the user includes this information in the "CROSS-REFERENCE TO RELATED APPLICATIONS" section.]
These applications constitute the direct patent family members from which US9005293 derives priority.
Divisional applications typically arise from restriction requirements by the USPTO examiner, where multiple inventions are claimed in a single application. The applicant can then file a divisional application for the non-elected invention(s) while retaining the priority date of the original application. The provided patent text does not explicitly mention any divisional applications stemming from the prosecution of US9005293 or its parent applications.
A search on the USPTO database for US patent 9005293 itself would be required to identify if any additional continuation or divisional applications have been filed from US9005293. The Google Patents information does list several other priority claims, suggesting a complex family tree. These include:
- US13/210,150 (priority to US9867719B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US13/210,162 (priority to US9895238B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US13/210,168 (priority to US9907674B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US13/210,157 (priority to US9889022B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US13/741,361 (priority to US9301854B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US14/063,197 (priority to US9848993B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US15/054,926 (priority to US9848998B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US15/820,232 (priority to US10016284B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US15/894,471 (priority to US10390969B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US15/944,117 (priority to US10537442B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US15/976,340 (priority to US10307268B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US16/018,354 (priority to US10376386B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US16/025,667 (priority to US10426633B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US16/280,684 (priority to US10478319B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US16/587,993 (priority to US11096797B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US16/744,755 (priority to US11376136B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US17/408,068 (priority to US12011367B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US17/706,873 (priority to US11903849B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
- US18/444,119 (priority to US12539219B2/en) [cite: The patent text provided by the user includes this information in the "Priority claimed from" and "Priority to" fields.]
These indicate a substantial and ongoing family of patent applications, likely comprising continuations and continuation-in-parts, demonstrating a strategy of maintaining protection over various aspects and developments of the original invention.
Projected Expiration Date
The standard term for a U.S. utility patent filed on or after June 8, 1995, is 20 years from its earliest effective filing date, not including any Patent Term Adjustments (PTA) or Extensions (PTE).
For US Patent 9,005,293, the earliest priority date claimed is April 12, 2005 (U.S. provisional application No. 60/670,231). [cite: The patent text provided by the user includes this information in the "Priority date" field.]
Therefore, without considering any PTA or PTE, the patent would expire 20 years from this priority date:
April 12, 2005 + 20 years = April 12, 2025.
However, the provided patent text from Google Patents states a "Legal status" of "Active, expires 2028-04-11". This "Adjusted expiration" date indicates that Patent Term Adjustment (PTA) has been applied. [cite: The patent text provided by the user includes this information in the "Legal status" and "Adjusted expiration" fields.]
Therefore, the projected expiration date for US Patent 9,005,293 is April 11, 2028. [cite: The patent text provided by the user includes this information in the "Adjusted expiration" field.] This date already incorporates any PTA granted during prosecution. It is important to note that this adjusted expiration date does not include any potential PTE, which would be granted for delays in regulatory approval of a product covered by the patent, if applicable.
Generated 5/28/2026, 1:56:54 PM